Evidence map›Paper›PMID 39920881›Full record

ArticleRenal failure2025

Impact of dialysis on intravesical recurrence and survival outcomes in upper tract urothelial cancer patients undergoing radical nephroureterectomy.

Chi-Chun Hsieh, Ching-Chia Li, Yung-Shun Juan, Wei-Ming Li, Wen-Jeng Wu, Tsu-Ming Chien

Abstract read
In one paragraph

Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chi-Chun HsiehDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Ching-Chia LiDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Yung-Shun JuanDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Wei-Ming LiDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Wen-Jeng WuDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Tsu-Ming ChienDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUpper tract urothelial carcinoma (UTUC) presents a significant recurrence risk following radical nephroureterectomy (RNU). Patients on dialysis may experience unique clinical trajectories due to uremic states and altered immune responses.

objectiveTo evaluate the impact of dialysis on intravesical recurrence and survival outcomes in patients with UTUC undergoing RNU, and to identify predictive factors influencing prognosis.

methodsA retrospective cohort study analyzed 402 patients with non-metastatic UTUC treated with RNU between 2001 and 2014. Patients were stratified into dialysis (

resultsDialysis patients were predominantly female, younger, and exhibited less advanced pathological tumor stages. Dialysis was associated with higher intravesical recurrence rates (

conclusionsDialysis does not independently worsen surgical outcomes or BRFS in UTUC patients post-RNU when accounting for prior bladder cancer. Prognostic models should integrate these findings to enhance individualized surveillance and treatment strategies.

Indexed as

Carcinoma, Transitional CellNeoplasm Recurrence, LocalNephroureterectomyRenal DialysisUreteral NeoplasmsUrinary Bladder NeoplasmsAgedAged, 80 and overFemaleHumansKaplan-Meier EstimateMaleMiddle AgedNeoplasm StagingPrognosisProportional Hazards Modelsdialysisend-stage renal diseasesintravesical recurrenceradical nephroureterectomyUpper tract urothelial carcinoma

Identifiers

PMID39920881
PMCPMC11809166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.